NeuroPlasma12

1. NeuroPlasma12 predicts Alzheimer's disease in silico (AUC 0.9410, 92.03% accuracy, p < 0.001).

   “NeuroPlasmaNet achieved 92.03% accuracy (AUC=0.9410, p < 0.001) for early AD detection using NeuroPlasma12 gene panel”

   In silicoearly Alzheimer's detection

   Non‐Invasive Blood‐Based Early Alzheimer’s Detection Using Sex‐Specific Brain‐Blood Graph Reinforcement Learning

   AAIC 2025 abstract·23 Dec 2025

More on Alzheimer's disease